JPS6358834B2 - - Google Patents

Info

Publication number
JPS6358834B2
JPS6358834B2 JP56191358A JP19135881A JPS6358834B2 JP S6358834 B2 JPS6358834 B2 JP S6358834B2 JP 56191358 A JP56191358 A JP 56191358A JP 19135881 A JP19135881 A JP 19135881A JP S6358834 B2 JPS6358834 B2 JP S6358834B2
Authority
JP
Japan
Prior art keywords
compound
ring
electrolysis
electrolytic
hydrogen fluoride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56191358A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5892680A (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP56191358A priority Critical patent/JPS5892680A/ja
Priority to US06/454,108 priority patent/US4526969A/en
Publication of JPS5892680A publication Critical patent/JPS5892680A/ja
Priority to US06/670,971 priority patent/US4591599A/en
Priority to US06/670,969 priority patent/US4599343A/en
Priority to US06/670,970 priority patent/US4596810A/en
Publication of JPS6358834B2 publication Critical patent/JPS6358834B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00—Electrolytic production of organic compounds
    • C25B3/01—Products
    • C25B3/05—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00—Electrolytic production of organic compounds
    • C25B3/01—Products
    • C25B3/09—Nitrogen containing compounds
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00—Electrolytic production of organic compounds
    • C25B3/01—Products
    • C25B3/11—Halogen containing compounds
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00—Electrolytic production of organic compounds
    • C25B3/20—Processes
    • C25B3/27—Halogenation
    • C25B3/28—Fluorination

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Electrochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
JP56191358A 1981-11-27 1981-11-27 パ−フルオロビシクロ化合物 Granted JPS5892680A (ja)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP56191358A JPS5892680A (ja) 1981-11-27 1981-11-27 パ−フルオロビシクロ化合物
US06/454,108 US4526969A (en) 1981-11-27 1982-12-28 Trifluoromethyl substituted perfluoro quinolizines
US06/670,971 US4591599A (en) 1981-11-27 1984-11-13 Perfluoropyrrolizines and emulsions thereof useful as blood substitutes
US06/670,969 US4599343A (en) 1981-11-27 1984-11-13 Perfluoroindolizines and emulsions thereof useful as blood substitutes
US06/670,970 US4596810A (en) 1981-11-27 1984-11-13 Emulsions of perfluoro octahydro quinolizines useful as blood substitutes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56191358A JPS5892680A (ja) 1981-11-27 1981-11-27 パ−フルオロビシクロ化合物

Publications (2)

Publication Number Publication Date
JPS5892680A JPS5892680A (ja) 1983-06-02
JPS6358834B2 true JPS6358834B2 (OSRAM) 1988-11-17

Family

ID=16273240

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56191358A Granted JPS5892680A (ja) 1981-11-27 1981-11-27 パ−フルオロビシクロ化合物

Country Status (2)

Country Link
US (1) US4526969A (OSRAM)
JP (1) JPS5892680A (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4596810A (en) * 1981-11-27 1986-06-24 The Green Cross Corporation Emulsions of perfluoro octahydro quinolizines useful as blood substitutes
JPS58170782A (ja) * 1982-01-22 1983-10-07 アイ・エス・シ−・ケミカルズ・リミテツド 過弗素化複素環式化合物およびこれを含むエマルシヨン
DE3366683D1 (de) * 1982-08-07 1986-11-13 Green Cross Corp Perfluoro-1-azatricyclic amine compound
US5684050A (en) * 1986-01-24 1997-11-04 Hemagen/Pfc Stable emulsions of highly fluorinated organic compounds
US5514720A (en) * 1986-07-09 1996-05-07 Hemagen/Pfc Stable emulsions of highly fluorinated organic compounds
US5243044A (en) * 1986-08-25 1993-09-07 International Therapeutics, Inc. Compounds of perfluoro[3,3,3]propellene and perfluoro hexamethylenetetramine
US5171755A (en) * 1988-04-29 1992-12-15 Hemagen/Pfc Emulsions of highly fluorinated organic compounds
US5403575A (en) * 1991-12-12 1995-04-04 Hemagen/Pfc Highly fluorinated, chloro-substituted organic compound-containing emulsions and methods of using them

Also Published As

Publication number Publication date
JPS5892680A (ja) 1983-06-02
US4526969A (en) 1985-07-02

Similar Documents

Publication Publication Date Title
US6210830B1 (en) Lithium fluorophosphates and their use as conducting salts
JPH08512095A (ja) ペルフルオロアルカンスルホニルフルオリドの製造方法
CA1250296A (en) Perfluorobicyclo compounds
JPS5892680A (ja) パ−フルオロビシクロ化合物
US4534978A (en) Perfluorocycloamines
EP0103358B1 (en) Perfluoro-1-azatricyclic amine compound
JPH0463055B2 (OSRAM)
EP0099652B1 (en) Perfluorotricyclic amine compound
JPH0144183B2 (OSRAM)
JPH0157108B2 (OSRAM)
JPH0216297B2 (OSRAM)
JPS642580B2 (OSRAM)
JPS6360025B2 (OSRAM)
CN1140475A (zh) 制备f-烷基f-异丁基醚的电化学氟化方法
EP0121614B1 (en) Perfluorotricyclic amine compounds
JPS591484A (ja) パ−フルオロ環状アミン化合物
JPS6133828B2 (OSRAM)
CA1189079A (en) Perfluorotricyclic amine compounds
US4235782A (en) Perfluoro(4-methyl-2-oxabicyclo[4.4.0]decane) and method for manufacture thereof
RU2615148C1 (ru) Способ получения перфтор-3-метоксипропионилфторида
JPS5924154B2 (ja) 新規なペルフルオロスピロ化合物
JPS58103334A (ja) パ−フルオロポリエ−テル及びその製造方法
CN103497216B (zh) 一种制备双(七氟异丙基)三氟化膦的方法
JPS595187A (ja) パ−フルオロ環状アミン化合物
JPS591485A (ja) パ−フルオロ環状アミン化合物